# Safety Evaluation of MSC-based Therapy for Liver Cihcrosis Treatment

> **NCT07472270** · PHASE1 · NOT_YET_RECRUITING · sponsor: **Vinmec Research Institute of Stem Cell and Gene Technology** · enrollment: 12 (estimated)

## Conditions studied

- Liver Cirrhosis

## Interventions

- **BIOLOGICAL:** Umbilical cord mesenchymal stem cell-derived extracellular vesicles

## Key facts

- **NCT ID:** NCT07472270
- **Lead sponsor:** Vinmec Research Institute of Stem Cell and Gene Technology
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-03-15
- **Primary completion:** 2026-12-31
- **Final completion:** 2026-12-31
- **Target enrollment:** 12 (ESTIMATED)
- **Last updated:** 2026-03-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07472270

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07472270, "Safety Evaluation of MSC-based Therapy for Liver Cihcrosis Treatment". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT07472270. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*